This is all the other psychedelic research that came out in September 2023. These papers don’t (yet) have their own page in our database.
You can find all interesting papers in our Papers Database.
Related Papers
In Rodents
- Gβγ subunit inhibitor decreases DOM-induced head twitch response via the PLCβ/IP3/Ca2+/ERK and cAMP signaling pathways (in mice, “Our results demonstrated that Gβγ subunits play an important role in the DOM-induced HTR. “)
- (R)-ketamine restores anterior insular cortex activity and cognitive decits in social isolation-reared mice (in mice, “…we found that social isolation attenuates aIC neuronal activation upon social contact and that (R)-ketamine, but not (S)-ketamine, is able to 52 counteracts this reduction.”)
Chemistry
- A molecular analysis of substituted phenylethylamines as potential microtubule targeting agents through in silico methods and in vitro microtubule-polymerization activity (analysis)
- Discovery and In Vitro Characterization of SPL028: Deuterated N,N-Dimethyltryptamine (chemistry, making of longer-lasting DMT analogue (SPL028)
- Elucidation of the mescaline biosynthetic pathway in peyote (Lophophora williamsii) (synthesis pathway)
- Synthetic Strategies toward Lysergic Acid Diethylamide: Ergoline Synthesis via α-Arylation, Borrowing Hydrogen Alkylation, and C–H Insertion (synthesis)
- Systematic characterization of Lysergic Acid Diethylamide metabolites in Caenorhabditis elegans by ultra-high performance liquid chromatography coupled with high-resolution tandem mass spectrometry (analysis in organism)
Perspectives/Opinions
- Adapting psychedelic medicine for headache and chronic pain disorders (perspective)
- Psychedelic Therapy—A New Paradigm of Care for Mental Health (editorial)
- A perspective on psychedelic teratogenicity: the utility of Zebrafish models (opinion)
- Regulating Ketamine Use in Psychiatry (editorial)
- Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression (response)
- From prohibited to prescribed: The rescheduling of MDMA and psilocybin in Australia (editorial)
- Current treatment options for cluster headache: limitations and the unmet need for better and specific treatments—a consensus article (consensus article, mentions psychedelics for cluster headaches)
- Challenges With Short-term Use of Intravenous Racemic Ketamine With Psychotherapy for a Hospitalized Patient With Severe Posttraumatic Stress Disorder and Depression (letter to the editors)
- Psilocybin for anorexia nervosa: If it helps, let’s learn how (viewpoint)
- Classic Psychedelics for the Treatment of Depressive Disorders: An Update for Psychiatrists in Training (perspective/guideline)
- “We don’t want to run before we walk”: the attitudes of Australian stakeholders towards using psychedelics for mental health conditions (perspective)
- Unlocking the potential of psychedelics as medicine: Past obstacles and future outlooks (viewpoint)
- Psychedelic drug MDMA moves closer to US approval following success in PTSD trial (news)
- The psychedelic experience and treatment-resistant depression (commentary)
- Lifeboat ethics, risk, and therapeutic opportunity: an appeal for equitable psychedelic therapy access in the “high-risk” addiction patient (perspective)
Reviews
- VR models of death and psychedelics: An ‘un-collapsed’ aesthetic paradigm for designing high-entropy experiences with ill-defined priors (pre-print, theory-building, VR x NDE / psychedelics)
- A journey with psychedelic mushrooms: From historical relevance to biology, cultivation, medicinal uses, biotechnology, and beyond (review)
- Psilocybin history, action and reaction: A narrative clinical review (review)
- Review of studies on the use of microdosing with hallucinogens that combine psychotherapeutic techniques with administrations of LSD, MDMA or Psilocybin, as pharmacological complements in chronic psychopathologies, moderate, high, severe or chronic disorders, as well as in life-threatening diseases (review)
- The zebrafish for preclinical psilocybin research (review)
- Molecular and structural insights into the 5-HT2C receptor as a therapeutic target for substance use disorders (review)
- Acute Subjective Effects of Psychedelics within and Beyond WEIRD Contexts (review)
- Ketamine Use in Adult and Pediatric Patients Receiving Extracorporeal Membrane Oxygenation (ECMO): A Systematic Review (review)
- Use of the Classic Hallucinogen Psilocybin for Treatment of Existential Distress Associated with Cancer (academic book chapter)
- DNA methylation and the opposing NMDAR dysfunction in schizophrenia and major depression disorders: a converging model for the therapeutic effects of psychedelic compounds in the treatment of psychiatric illness (review)
- Psychedelic-Assisted Therapy in Military and Veterans Healthcare Systems: Clinical, Legal, and Implementation Considerations (review)
- The efficacy and safety of esketamine in pediatric anesthesia: A systematic review and meta-analysis (review & meta-analysis)
- Use of Psychedelics for Pain: A Scoping Review (review)
- Treatment-resistant depression: definition, prevalence, detection, management, and investigational interventions (review, covers ketamine)
- Do Psychedelics Facilitate Emergence of Unconscious Psychological Processes? (review)
Other
- Case report: Ibogaine reduced severe neuropathic pain associated with a case of brachial plexus nerve root avulsion (n=1, case study, “…we describe a 53-year-old male with two decades of severe intractable pain due to brachial plexus nerve root avulsion from vehicular trauma who was successfully treated with both high dose inpatient and low dose outpatient administrations of ibogaine.“)
- History of the administration of psychedelics in France (history, “With just a few rare cases of recovery reported, these substances were not considered as medicines, but rather as tools for exploration in the context of experimental research; thought of not as psychedelics (“mind manifesters”) but as psychodysleptics (“mind disruptors”)“)
- Not New, but Nearly Forgotten: Hypnodelic Therapy as Treatment for Addiction (student review, LSD x hypnosis)
- Healing Words: Effects of Psychoeducation on Likelihood to Seek and Refer Psychedelic-Assisted Psychotherapy Among BIPOC Individuals (effect of education on likelihood of seeking PAT)
- Therapeutic effects of 7- to 14-day subanesthetic ketamine infusions for chronic pain on standardized psychiatric measures (ketamine for pain, “There was a significant 52% reduction in pain severity and 33% reduction in pain interference scores following ketamine treatment. Ketamine treatment also reduced scores on the depression module of the Patient Health Questionnaire (PHQ-9) by 28% and scores on the Generalised Anxiety and Depression Assessment (GAD-7) by 36%.“)
- Therapeutic Effects of Ceremonial Ayahuasca Use for Methamphetamine Use Disorders and Other Mental Health Challenges: Case Studies in an Indigenous Community in Sonora, Mexico (n=3, case studies, “The preliminary results demonstrate therapeutic progress and improved psychometric outcomes observed in the three case studies presented, indicating promise for this intercultural therapeutic intervention.“)
- Efficacy of Psilocybin-assisted Psychotherapy for Treatment-resistant Depression: a Comparative Meta-analysis (thesis)
- Potential Benefits of Psilocybin for Lupus Pain: A Case Report (n=1, case report)
- Testing the activity of novel psychedelics on the 5-HT2A and 5-HT2B receptor (master thesis)
- Ketamine and Transcranial Magnetic Stimulation in an Adolescent with Treatment-Resistant Depression (case study, n=1, adolescent x ketamine & TMS)